CHAPTER OBJECTIVES
At the end of this chapter, the learner will be able to:
Describe the sequence of normal acute wound healing.
Identify the cells that direct activity in the healing cascade.
Describe the chemical messengers necessary for timely wound healing (including the cells of origin, target cells, and actions).
Classify the primary enzymes produced during healing (including the cells of origin and actions).
Describe the inate and adaptive immune responses that occur during wound healing.
Describe the functions of platelets, monocytes, and fibroblasts and how they change during the course of wound healing.
Explain the differences between normal acute and chronic wound healing.
Perhaps the hamartia, or the flaw, in the study of wound healing is the tendency to oversimplify the truly elegant system that ensures healing, both anatomically and functionally. The multitude of processes that ensure wound closure and the commensurate return of function are equally marvelous.
The illustrations in this chapter introduce the interplay of cellular and molecular signaling in conjunction with vascular events that occur during the healing process. The figures demonstrate how cells involved in the repair process are directed, based upon global and local stimuli that may be cytokine, chemokine, pH, or galvanically driven.1,2 If invaders or pathogens (eg, bacteria, fungi, viruses, or debris) are present, innate immune cells migrate and proliferate to the site of injury.3 These cells include macrophages, neutrophils, natural killer (NK) cells, and gamma delta T cells. If the invader is a repeat offender that the host has successfully fended off previously, adaptive immune responses (B cell clonal expansion) are triggered.3–5 Simultaneously, debris (necrotic and/or injured cells) is removed and a new wound bed excavated via proteases and extracellular matrix (ECM) degradation. This serves two purposes: (1) the clearance of cell and invader refuse and (2) the provision of pathways for cellular migration and proliferation, which constitute repair.2
The signaling in wound healing, renewal, and regeneration is a product of many factors, including the concentration and timing of chemical signal delivery, target cell receptor availability, active form after cleavage, degradation rate, messenger half-life, pH and presence of enzymes (eg, proteases) in the wound milieu, hydrophobicity, and hydrophilicity. Scaffold-binding (via heparin activation or other mechanisms), fiber type (whether fibrin or collagen), cell shape, adhesion interfaces (via integrins), and storage of growth factors all contribute to the timing and intensity of cell signaling during wound healing. These factors work together to drive growth factor, cytokine, and chemokine bioavailability, thus resulting in wound healing.
Vascular changes occur as a result of endothelial cell activation, migration, and capillary expansion in response to tissue hypoxia and increased lactic acid concentration.6–8 Phenotypical changes in prominent cells (platelets, macrophages, and fibroblasts) are important in directing healing through the influence and production of many of the chemical messengers. The macrophages have a pronounced cellular functional metamorphosis and are the central orchestrators of the healing process. Cellular roles pertinent to wound healing are depicted in TABLE 2-1 along with the cellular communication and signaling that occur to effect progression through the healing process.
Endothelial Cells Description: | Cell Graphic | |
PRIMARY ACTION | EFFECT | MECHANISM/SIGNAL |
Reestablishment of ECM | Fibroblast proliferation | Acidic fibroblast growth factor (aFGF) |
Facilitate in angiogenesis | Facilitation of the reestablishment of the vascular base including the reabsorption of excess capillaries | Basic fibroblast growth factor (bFGF) |
VEGF is a potent stimulator of angiogenesis | VEGF—upregulated in the presence of nitric oxide | |
Angiogenesis | Angiogenesis is further facilitated by the secretion of PDGF and the upregulation of target cell receptors for PDGF (PDGFRs). Cells primed with PDGFRs include circulating progenitor cells, both endothelial and pericyte cells9 | PDGF platelet-derived growth factor. (This is a family of growth factors, with five members)10 |
Epithelial Cells Description: | Cell Graphic | |
PRIMARY ACTION | EFFECT | MECHANISM/SIGNAL |
Attracts platelets | Chemo attraction to injury site | PDGF |
Increases vascular permeability | In response to injury, increased vascular permeability allows movement of other key cells (neutrophils, macrophage) into the interstitial space | VEGF |
Increase other cells’ motility and proliferation | Pleiotropic cell motility and proliferation. Regeneration of the epidermis and other mesenchymal cells | TGF-α |
Stimulates angiogenesis | Facilitation of the reestablishment of the vascular base including the reabsorption of excess capillaries | Basic fibroblast growth factor (bFGF) |
VEGF | ||
TNF-α | ||
Formation of granulation tissue during proliferation | Increased granulation tissue in wound bed/base | Insulin-like growth factor (ILGF) |
Final re-epithelialization | Reestablishes epithelial barrier | ILGF |
Fibroblasts Description: | Cell Graphic | |
PRIMARY ACTION | EFFECT | MECHANISM/SIGNAL |
Pro-inflammatory | Stimulate neutrophil development | IL-1—amplifies inflammatory response by increasing synthesis of itself (IL-1) and IL-6 |
Site-specific migration | Respond to aFGF and bFGF | |
Both a constructor and a component of granulation tissue | Elastin production GAGs | Connective tissue growth factor (CTGF)11,12 |
Adhesive glycoproteins produced on the cell surface anchor the fibroblasts to other cells and proteins in the extracellular matrix | ||
Change phenotype | During late stage proliferation, fibroblasts morph into myofibroblasts to help bridge the “gap” between the wound edges13–15 | Differentiation initiated by TGF-β13 |
Collagen production | Direct collagen matrix | Production of fibrin, fibronectin |
Recruitment of other key cells | Endothelial cells | Activated macrophage induce in vitro keratinocyte growth factor (KGF) |
Keratinocytes16 | ||
Epithelialization | Directs epithelialization and enables cellular migration | KGF2 |
Differentiate into Myofibroblasts | Epidermal cell motility and proliferation to reestablish intact skin | KGF |
Scar contraction | The myofibroblasts pull the newly formed regranulated/scar base together | Actin (REF) |
Granular tissue formation and remodeling | Remodeling of the ECM | ILGF-1 |
Inhibits and shuts down the tissue MMPs | TGF-β | |
Keratinocytes Description:
| Cell Graphic | |
PRIMARY ACTION | EFFECT | MECHANISM/SIGNAL |
Entry to site a few hours after injury | Migrate over wound bed at the interface between the wound dermis and the fibrin clot | Facilitated by production of specific proteases (eg, collagenase by epidermal cells, which degrades the ECM)17–19 |
↑ Keratinocyte recruitment | Stimulate keratinocytes and induce keratinocyte site specific proliferation | IL-6 |
Vitamin D3 synthesis | Key to antimicrobial peptide production | Only cell in the body, which can complete both hydroxylation steps to activate Vitamin D3 |
De Novo Hair Follicle Formation | Can contribute to hair follicle formation | Site of epidermal stem cells continued proliferation of keratinocytes |
Recruit macrophage | Migration to and cross talk with macrophage | Cytokines, chemokines, interleukins, growth factors20,21 |
Migration and proliferation | Cross talk with macrophage | Activation of epithelial growth factor receptor (EGFR) expressed on keratinocytes Macrophage-produced EGF |
Neo-angiogenesis | Provide nutrients and oxygen for new tissue synthesis | Production of VEGF (↑ VEGF indirectly promoted by macrophage secretion of TNF-α and TGF-β)22 |
Macrophage Description: | Cell Graphic | |
PRIMARY ACTION | EFFECT | MECHANISM/SIGNAL |
Early surveillance | Bacterial replication activates Binding of bacterial components via membrane proteins, for example, toll-like receptor 4 (TLR4), and causes the release of pro-inflammatory cytokines24 | Release of IL-1β, IL-6, TNF-α17 |
Phagocytosis | Binding of bacterial components Binding of immunoglobulins24 | Presence of pathogens, apoptotic cells (including neutrophils)4 |
Wound debridement | Clearing of damaged vessels, necrotic cells, and ECM Pro-inflammatory | Granulocyte-macrophage colony-stimulating factor (GM-CSF) Granulate colony-stimulating factor (G-CSF) Enzymes produced by the macrophage include collagenase and elastase |
Recruitment of other cells | Essential for entry of angioblasts, keratinocytes, endothelial cells, and fibroblasts | Cytokines, chemokines, fibronectin, IL-1, INF-γ, TNF-α, and growth factors including PDGR, TGF-β, EGF, and IGF16 |
Inflammation | Wound Associated Macrophage Central role in the control of inflammation. Upregulation of MMP transcription and nitric oxide (NO) synthesis. TNF-α induces MMP transcription and stimulates the production of NO. Promotes wound closure in normal conditions but are also associated with fibrosis and scar formation5 | IL-1β IL-6 TNF-α17 |
Plastic cells | Switch from one functional subpopulation to another depending on the stimulus received25 | Bacteria, quorum sensing, wound milieu25 |
Coordination of neo-angiogenesis | New vessel formation in the wound bed and surrounding periphery | Stimulates VEGF production by keratinocytes22 |
Stimulate matrix production and regulation | Initially collagen type III is deposited in the wound; however, macrophages are key in each step as listed below.
| Growth factor TGF-β1 and TGF-β2 are associated with inflammation and TGF-β3 is associated with scar-free wound healing26 |
Remodeling | Re-epithelialization from the very first day! Wound activated macrophage (WAM) promotes key cell (keratinocyte and endothelial and epithelial cells) migration via the release of proteases to selectively degrade the ECM27 | Collagenase secretion Lytic enzyme secretion TGF-β |
Platelets Description:
| Cell Graphic | |
PRIMARY ACTION | EFFECT | MECHANISM/SIGNAL |
Immediate entry into site | Release prothrombin and thrombin to bind-free floating fibrin (from the liver that is found in circulating plasma) | Change in platelet cell shape Change in cell receptors—Receptors displayed on the platelet surface for fibrin and clotting factors, specifically the von Willebrand adhesion factor (Factor VIII). |
Entry to site a few hours after injury | Migrate over wound bed at the interface between the wound dermis and the fibrin clot | Facilitated by production of specific proteases (eg, collagenase by epidermal cells, which degrades the ECM)17–19 |
Increases chemotaxis of neutrophils, macrophages, and fibroblasts | Recruitment of macrophage to site of injury to clear and contain invader | Platelet-derived growth factor (PDGF) Tissue growth factors (TGF-β1 and TGF-β2 from platelets) |
Delays new vessel formation until clot stable and debris cleared | Inhibits angiogenesis | Endostatin28 |
Proliferation | Extracellular matrix (ECM) synthesis and remodeling | Tissue growth factors (TGF-β1 and TGF-β2 from platelets) |
Increased epidermal cell motility | Important in neo-angiogenesis and proliferation phase for reestablishment of epidermal barrier | TGF-β1 and TGF-β2 (from platelets) |
Significant source of growth factors | Platelet-derived growth factor (PDGF) TGF-β1 and TGF-β2 Keratinocyte growth factor (KGF) Epidermal growth factor (EGF) Insulin-like growth factor (IGF) | |
Polymorphic Neutrophilic Leukocytes (PMNs) Description:
| Cell Graphic | |
PRIMARY ACTION | EFFECT | MECHANISM/SIGNAL |
Short life span | Survive <24 hours4,31 | Migrate from capillaries to interstitial space in response to chemokines29 |
Site-specific migration | Respond to infection ↑ in adhesiveness ↑ in cell motility ↑ in chemotactic response | ↑ Vascular permeability Local prostaglandin release Presence of chemotactic substances (complement IL-1, TNF-α, TGF-β, platelets)30–34 |
First inflammatory cells recruited to the clot | Emigrate to the new wound and soon after enter apoptosis | Cytokine release35,36 |
Phagocytosis | Free radical production Scavenging of necrotic debris, bacteria, and foreign bodies | Release of oxygen radicals including H2O2, O2−, OH− Nitric oxide |
Entrapment | Trap invading bacteria for phagocytosis by macrophage. DNA NETs contain decondensed chromatin, bound histones, azurophilic granule proteins, and cytosolic proteins44,45 | DNA neutrophil extracellular traps (NETs)45 |
Lysis of invaders | Major source of proteases | Release proteases |
Recruitment of other key phagocytic cells Resolution of inflammation | Particularly recruit and intensely stimulate macrophage.46 In fact, the final stage of neutrophil differentiation is the induction of apoptosis, which causes the recognition by phagocytes/macrophages. This assists with clearing invaders and promotes inflammation, endothelial activation,47 and eventually the resolution of inflammation48–50 | Apoptosis (programmed cell death) of neutrophils49–51 TNF-α (cachectin) |
The pivotal cells and phases of healing are depicted in TABLE 2-2, which provides a cross-reference of healing phases with key cells and signals, as well as a chronological timeline, thus providing the reader an appreciation of the overlapping and essential functions directed in sequence as opposed to an isolated view of cell function. Although exceedingly complex, the elegance of the healing response lies both in the ability of multiple systems to evoke healing and in the use of paracrine, autocrine, and juxtacrine mediators to effect expedient resolution of tissue injury using the resources immediately available.
Clinical Presentation | Normal | Predominant Cell/Tissue Type |
Hemostasis (<1 hour) | Cellular Activity Clot formation
| Predominant Tissue Type/Cell Platelet |
Vascular events |
| |
Cellular events |
| |
Cell signaling |
| |
Clinical signs |
| |
Inflammation (1 hour–4 days) | Reactive Chemotaxis/Scavenge
| Predominant tissue type/cell macrophage (WAM) |
Vascular events |
| |
Cellular events |
| |
Cell signaling |
| Predominant tissue type/cell macrophage (WAM) |
Clinical signs |
| |
Proliferation (4–12 days) Extracellular matrix | Repair 80% completed Laminin
|
|
Vascular events |
| |
Cellular events |
| |
Cell signaling |
TNF-α (from neutrophils) | |
Clinical signs |
|
|
Maturation and remodeling | Contraction Fibroblasts differentiate to myofibroblast Migration of melanocytes functional/scar remodel
| |
Vascular events |
| |
Cellular events |
| |
Cell signaling |
| |
Clinical signs | Blanching |
Cells exhibit various levels of activity in response to many factors. FIGURE 2-1 illustrates four recognized levels of cellular activity and the associated effect on local tissue environment. Cells that exist in a senescent state (defined as resistant to apoptosis or programmed cell death) disrupt normal tissue differentiation, drain the metabolism, and secrete cell products that negatively impact the wound environment. Cells in a baseline state have normal mitotic and metabolic activity, actively survey and monitor adjacent tissues, and do not impact surrounding tissues negatively. An upregulated state has a higher level of metabolic activity and purposefully responds in concert with other cells in reaction to injury, presence of pathogens, or both. A cell that is out of control exhibits an overproduction of cellular byproducts, is not coordinated with any other cells, and does not respond to feedback inhibition. The cartoons that represent each level of cell activity are overlaid in important diagrams to help the reader discern the cellular state in normal and disrupted wound healing. Both the correct cells and the appropriate level of cellular activity are required to ensure wound healing.
FIGURE 2-1
Levels of cellular activity
This figure provides an explanation of various cell activity levels and the observed cellular events associated with that level of cellular activity. The cartoons illuminate the cell state and are used throughout the chapter to illustrate whether the level of activity is appropriate or inappropriate, as well as the ramifications.
FIGURE 2-2 provides an illustration of the intricate and exquisite sequence of cell migration, proliferation, and signaling in the context of cell signaling and vascular events, all working in unison to culminate in tissue healing.
FIGURE 2-2
Cell migration, proliferation, and signaling in the wound healing process
The healing map is a summary of both the acellular and cellular components of wound healing. This illustration is parsed by phases of healing along the horizontal axis, while the primary cells of importance are along the vertical axis.
The cytokines, chemokines, and growth factors important at each phase are depicted along with the directional impact exerted on healing by each of these components. The direction is indicated by color-keyed arrows.
The healing response occurs by one of the following four mechanisms: (1) continuous cell cycling, (2) cell proliferation, (3) regeneration, or (4) fibroproliferative response. Normal intact skin is representative of continuous cell cycling whereby labile cells are constantly undergoing a balance of proliferation and programmed apoptosis throughout life, thereby resulting in a steady state. The basal keratinocytes continuously undergo mitosis (cell division), followed by migration to the skin surface and subsequent desquamation or sloughing. Cell proliferation occurs when the damaged or lost tissue is replaced by the expansion of remaining healthy cells that undergo mitosis. The structure is not completely duplicated; however, function is approximated.
Regeneration occurs with the loss of a structure. The acute injury that undergoes regeneration stimulates complete duplication in both structure and function of the lost tissue. The liver, hematopoietic tissue, gastrointestinal tract epithelium, and epidermis are examples of tissue that are capable of regeneration. Fibroproliferative healing typically occurs in dermal wound healing. The lost tissue is not replaced, but rather a “patch” is constructed that restores the skin covering, integrity, and function. Inflammed tissue that fails to progress to healing results in tissue fibrosis. Divisions of wound healing are graphically depicted in FIGURE 2-3.
FIGURE 2-3
Divisions of wound healing
The body responds to tissue injury in mechanisms that result in tissue regeneration, thus restoring both structure and function of that specific tissue. The four pathways of response are regeneration, compensatory growth, renewal, and fibrosis. When regeneration of epithelium or the underlying tissue fails to occur in a timely fashion, a state of chronic inflammation usually results.
Wound healing can be classified by category or by depth; both assist clinicians in communicating clearly regarding patient needs. Four categories describe wound healing—categories 1 to 3 describe healing of full thickness wounds while category 4 refers to partial thickness skin wounds.53,54
Category 1 (Primary Intention) healing occurs when a clean surgical incision is created and the resulting wound is free from contamination of bacteria, fungi, or foreign bodies. There is minimal tissue loss and the edges can be safely approximated and secured with sutures, staples, or surgical glue. The clotting cascade at the wound surface is largely not initiated and the resulting fibrous scab is absent because of the minimal mortality of cells central to wound healing. The cell signaling cascades usually launched in an acute penetrating injury are not activated. This incisional wound resolves in an orderly, sequenced manner over the course of approximately two weeks (FIGURE 2-4).55
FIGURE 2-4
Healing by primary intention
A–C. The series of three images illustrate the tissue response to an incision. Focal disruption and tissue stabilization by suture result primarily in epithelial regeneration.
D. Sutures are used to close a surgical incision by primary intention. Healing is achieved when the new epithelium bridges the gap between the two edges, and minimal scar is formed. E. The left aspect of this groin incision illustrates closure by primary intention where the epithelium has bridged the incision. In the remaining part, the incision has separated in part because of the amount of moisture that has dissolved the superficial sutures without full skin growth. The incision is termed separated if the gap is less than 1 cm; dehiscence, if more than 1 cm.
Category 2 (Delayed Primary Intention) healing occurs when wound edges are not approximated because of the concern for the presence of pathogens or debris, an existing abscess, or loss of extensive tissue (FIGURE 2-5). Delayed primary wound healing is set in motion by the release of multiple pro-inflammatory cytokines, chemokines, and growth factors. Foreign debris is walled off by macrophages that may metamorphose into epithelioid cells, which in turn become encircled by layers of mononuclear leukocytes. The layers of mononuclear leukocytes can be compared to the sequential layering of nacre on a pearl—the clam overlays the grain of sand with nacre, smooth and protecting. In a wound, the result is a granuloma, with the foreign body or pathogen at the center, walled off from the host tissue. In these wounds the inflammatory response is more intense and is accompanied by increased granular tissue formation.55
FIGURE 2-5
Healing by delayed primary intention Large wounds can be partially closed with retaining sutures, or in the case of this abdominal wound, with tension sutures. This technique is used if approximating the edges puts too much strain on the periwound skin and subcutaneous tissue or if there is concern for infection and drainage that needs to be removed in order to prevent abscess formation.
These wounds frequently undergo delayed surgical closure after surgical removal of the granuloma, abscess, or debris. Once the wound is determined to be ready for closure, surgical intervention (such as suturing, skin graft placement, or flap design) is performed, provided the wound edges can be approximated. If the host-initiated cleansing, termed autolysis, of the wound is incomplete, chronic inflammation can ensue. Without further intervention, the result is likely to be prominent scarring.
Category 3 (Secondary Intention) healing is entirely accomplished through an appropriate inflammatory response, granulation tissue formation and re-epithelialization. Left to close without surgical intervention, wound contraction by myofibroblasts plays a significant role. The myofibroblasts have characteristics of smooth muscle cells and, when activated, they contract and thereby assist in consolidating the extracellular matrix and decreasing the distance between the dermal edges. The myofibroblasts are maximally present in the wound from approximately 10 to 21 days post-wounding.14 Additional time may be required for these wounds to close depending on the surface area and depth (volume) of the wound (FIGURE 2-6).55
FIGURE 2-6
Healing by secondary intention
When there is extensive tissue loss or contamination, the repair process increases in complexity as illustrated by a robust inflammatory response and an abundance of granulation tissue. A–C. The series of three illustrations highlights these attributes along with wound contraction through the action of myofibroblasts. A. Dehisced surgical incision on the medial thigh, approximately 24 hours after the site was irrigated and drained surgically. The wound is in the inflammatory phase of healing. B. The same wound two weeks later is in the proliferative phase with granulation visible throughout the wound bed. C. Two weeks later the wound is significantly smaller, and the incision along the lower leg is observed to be closed and remodeling. The wound completed closure by secondary intention without further surgical intervention.
Partial thickness wounding refers to partial loss of the epidermis or loss of the epidermis and superficial dermis (the basement membrane is intact and the hypodermis is not exposed). In this case healing is accomplished by epithelial cell mitosis and migration. Wound contracture is not an expected or common occurrence during the healing of partial thickness wounds, as the sub-dermal layers are not involved and minimal to no granulation tissue is formed (FIGURE 2-7).55
FIGURE 2-7
Healing of a partial-thickness wound Re-epithelialization can be seen at the wound edges, as well as on the small “epithelial island” at the lower edge. The island indicates that the epithelial cells in that region are migrating from the hair follicle rather than the edge and is commonly seen in partial-thickness wounds.
Wounding can also be categorized by the depth and involvement of tissue lost or damaged as a result of the injury. These classifications progress from the most superficial erosion, to partial thickness of the dermis, and full thickness extending into the hypodermis. (Refer to Chapter 1, Anatomy and Physiology of the Integumentary System.)
Acute wound healing is divided into the following phases: hemostasis, inflammation, proliferation, and remodeling. Inflammation is further subdivided into three overlapping phases: kill/contain the invader, inflammation, and neo-angiogenesis. FIGURES 2-8 to 2-14B provide a framework for each of the major healing phases in terms of four important events: (1) vascular, (2) cellular, (3) cell signaling, and (4) clinical signs. FIGURES 2-8 and 2-9 depict normal intact skin prior to wounding; FIGURE 2-10, hemostasis; FIGURES 2-11A to 2-13B, inflammation; and FIGURES 2-14A to 2-16, proliferation. The interplay between each of the four phases is both complex and transitional such that within any wound, signs of more than one phase may be present. Vascular, cellular, and tissues changes that occur during the four phases include the following:
Vascular events include hemostasis, transient vasoconstriction, retrograde degradation of damaged vessels, and the transition to endothelial cell differentiation, migration, and proliferation—also termed neo-angiogenesis.
Cellular events include the directed migration and accumulation of cells known to be necessary for wound healing (eg, neutrophils and macrophages) to the site of injury.5 Some cells (platelets, macrophages, and fibroblasts) morph in both phenotype and function, depending on the phase of healing and the surrounding stimuli, whether cytokine, chemokine, or ECM activation.5
Cell signaling orchestrates healing by the actions of cytokines, chemokines, growth factors, and receptor accessibility on target cells. It is accomplished through the binding of chemical messengers to cell receptors present on the target cell surface. The binding of the chemical messenger (eg, cytokine, chemokine, growth factor, or interleukin) activates or depresses target cell DNA transcription and protein translation of important activities that are performed by the target cell. These activities include (a) the production of additional chemical messengers, (b) a change in cell phenotype and function, or (c) binding to adjacent ECM sites. Cell signaling occurs between cells (cell to cell) and between the cell and wound matrix (cell to matrix).56
Clinical signs and symptoms include changes observed in the local periwound environment (pain, redness, and edema) or systemic symptoms detected in the patient (fever, chills, increased heart rate, or pain).
FIGURE 2-10
Hemostasis
A. Hemostasis is the first phase of wound healing and is characterized by vasoconstriction of the injured vessel followed by vasodilation of the adjoining vasculature. Platelets aggregate and, along with fibrin, form a stable clot. At the wound site, platelets release molecules to stimulate platelet aggregation and growth of tissues important to healing. In the dermis and epidermis, PMNs and macrophages aggregate to kill and contain pathogenic invaders. The brown cells represent the pathogens.
B. The fasciotomy wound has not yet achieved hemostasis, as evidenced by the bleeding occurring at the inferior undermining of the wound.
FIGURE 2-11A
Inflammatory phase: contain and kill the invader
Inflammation is the second phase and has three sub-phases: killing and containing the invader, wound debridement, and neo-angiogenesis. During the process of killing and containing the invader both the innate and the adaptive immune systems are triggered and an inflammatory response initiated.
FIGURE 2-12
Inflammatory phase: wound debridement
A. During the wound debridement phase of inflammation, macrophages are activated and begin phagocytosis of cellular debris while releasing enzymes to liquefy the ECM.
Activated macrophage phagocytosis of cellular debris and release of enzymes.
Macrophage phagocytosis of Streptococcus.
Apoptosis of neutrophils, formation of neutrophil NETs, trapping Staphylococcus aureus in preparation for phagocytosis by macrophages.
Macrophage recruitment, secondary to neutrophil apoptosis.
Platelet aggregation and entrapment in fibrin.
Macrophage phagocytosis of cellular debris and release of cytokines.
Adhesion of neutrophils to endothelium in preparation for exocytosis.
Opsonization of Staphylococcus aureus with antibody and phagocytosis by neutrophils.
B. The necrotic tissue, termed eschar, on the wound surface will be attacked from the lower side by the macrophages and other phagocytic cells.
FIGURE 2-13A
Inflammatory phase: neo-angiogenesis
In preparation for proliferation, angiogenesis begins to (1) support new tissue formation and (2) facilitate the removal of debris and waste products as a result of the destruction of cells and tissue.
Growth factors are released from the platelets, including PDGF, TGF-β, bFGF, EGF, KGF, and IGF.
ECM matrix formation begins accelerating with the formation and release of collagen, elastin, GAGs, and adhesive glycoproteins.
Pro-inflammatory cytokines from the macrophages and other sources (including IL-1, IL1β, IL-6 and TNF-α) are being down-regulated and have a diminishing effect.
Neutrophils release free radicals (including H2O2, O2–, and OH–), which are destructive to bacteria in the wound milieu.
Clonal expansion of specific B cells begins after the dendritic cells present Streptococcus antigen in local lymph nodes.
Antibodies released by B cells opsonize specific target cells and provide a further signal for neutrophil engulfment.
Macrophages release VEGF to stimulate endothelium progenitor cell recruitment and differentiation as well as endothelial mitosis.
The foundation of proliferation is accomplished including the following actions: covering of the anatomical structures, restoration of immune barrier, construction of ECM, fabrication of endothelium, and restoration of circulation with vascular reconstruction.
FIGURE 2-14A
Proliferation
Proliferation is a complicated and intricate process composed of the following:
Epidermal stem cell activation.
Keratinocyte migration from epidermal stem cells.
Increased mitosis of basal epithelial cells.
Macrophage scavenging cellular debris, and collagen for remodeling while simultaneously releasing enzymes.
Laminin attaches to collagen and fibroblast cells via adhesins.
Macrophage continues to phagocytose fibrocytes and collagen to facilitate migration.
Elastin (pink) and collagen (silver) are important components in the restoration of function.
Fibroblast differentiates into myofibroblast evidenced by the presence of α contractile fibers.
Macrophage phagocytosis of the old clot (old fibrin, platelets and RBCs).
Endothelial progenitor cells are attracted by VEGF and other factors.
Vasodilation facilitates the process of tissue construction.
FIGURE 2-14B
Proliferation
In addition to the visible bright-red granulation tissue in the wound, the results of myofibroblasts can be seen around the edges where the wound bed has contracted and re-epithelialized. The top edge is rolled with senescent cells at the edge of the wound bed, a condition termed epibole.
FIGURE 2-15
Angiogenesis
Angiogenesis is the process of new blood vessel formation. The flowchart demonstrates that angiogenesis begins immediately after injury and proceeds through a very orderly sequence, stimulating the extravasation and migration of cells through gaps in the endothelium and progressing through the formation of endothelial cells. The formation of tubules and lumen provides the basis for basement membrane deposition and capillary maturation. Angiogenesis ensures nutrition availability and removal of waste products throughout the healing process.
Cytokines are small proteins or glycoproteins that are secreted by numerous cells and alter the function of the target cell. The target cell for the cytokine/interleukin may be itself (autocrine) or a neighboring cell (juxtacrine). Cytokines can be either pro-inflammatory or anti-inflammatory.
Interleukins are a group of cytokines that were first observed being expressed by white blood cells (leukocytes).1 The term interleukin derives from inter as a means of communication, and leukin, deriving from the fact that leukocytes produce many of these proteins and are the target of their action. The name is something of a relic as it has been determined that interleukins are in fact produced by a wide variety of body cells. The function of the immune system depends in a large part on interleukins, the majority of which are synthesized by helper CD4+ T-lymphocytes, as well as monocytes, macrophages, and endothelial cells.3
TABLE 2-3 lists the cytokines important to wound healing. The pro-inflammatory cytokines necessary for wound healing are TNF-α, IL-1, IL-2, IL-6, IL-8, and IFN-γ. In general, IL-4 and IL-10 are considered anti-inflammatory. Receptor expression on target cells can be either up- or down-regulated. Each of the signals and the complex interplay serves to enhance, depress, or change entirely the cell function while ensuring that the process culminates in functional wound healing.
Interleukins | Principal Source | Primary Activity | Comments |
IL-1α and IL-1β | Epithelial cells, fibroblasts, platelets, macrophages, and other antigen presenting cells (APCs) | Costimulation of APCs and T cells, inflammation and host fever, hematopoiesis | Acute phase response |
IL-2 | Activated Th1 cells and NK cells | Proliferation of B cells and activated T cells, NK cell function Regulate WBCs | |
IL-4 | Th2 and mast cells, basophils | B-cell proliferation, eosinophil and mast cell growth and function, IgE and class II MHC expression on B cells, inhibition of monokine production Th0 differentiated to Th2 cells, Th2 cells produce ↑ IL-4 Promotes macrophage 0 to differentiate to M2 macrophage; M2 macrophages are considered repair macrophages and coupled with the secretion of IL-10, TGF-β resulting in decreased inflammation and diminution of pathological inflammation | |
IL-6 | Activated Th2 cells, APCs, adipocytes, macrophages, hepatocytes, PMNs, and fibroblasts | Acute phase response, B-cell proliferation, thrombopoiesis. IL-6 works synergistically with IL-1β and TNF on T cells ↑ Production of neutrophils in bone marrow | Both pro- and anti-inflammatory Also considered a myokine—produced in response to repetitive muscle contraction |
IL-8 | Macrophages, epithelial, endothelial, fibroblasts, and other somatic cells | Chemoattractant for neutrophils and T cells Induces phagocytosis. IL-8 can be secreted by any cell with toll-like receptors that are involved in the innate immune response. Usually, it is the macrophage that “see” the invader first Promotes angiogenesis | Capable of crossing blood–brain barrier |
IL-10 | Activated Th2 cells, CD8+, T and B cells, macrophages, monocytes, and mast cells | Inhibits cytokine production, promotes B-cell proliferation, survival and antibody production, suppresses cellular immunity and mast cell growth Down-regulation of MHC Class II receptor expression | Anti-inflammatory Also known as human cytokine inhibitory factor Inhibition of TNF-α, IL-1 and IL-6 production and inhibition of PMN activation |
IL-12 | B cells, T cells, macrophages, dendritic cells | Proliferation of NK cells ↑ Cytotoxic activity of NK cells Th0 to Th1 INF-γ production, promotes cell-mediated immune functions Antiangiogenesis via ↑ production of INF-γ | Two different protein chains, which form three distinct dimers: AA, AB, BB |
IL-13 | Th2 cells, B cells, macrophages | Stimulates growth and proliferation of B cells, inhibits production of macrophage inflammatory cytokines Induces MMPs Induces IgE secretion from activated B cells | |
IL-18 | Macrophages | Increases NK cell activity, induces production of INF-γ Induces cell-mediated immunity Stimulates NK cells and T cells to release INF-γ | Pro-inflammatory Also known as INF-γ-inducing factor |
INTERFERONS | |||
INF-α, INF-β, INF-γ | Macrophages, neutrophils | Antiviral effects, induction of class I MHC on all somatic cells, activation of NK cells, and macrophages | |
INF-γ | Activated Th1 and NK cells, cytotoxic T cells | Induces expression of class I MHC on all somatic cells, induces class II MHC on APCs and somatic cells, activates macrophages, neutrophils, NK cells, promotes cell-mediated immunity, antiviral effects Activates inducible NO synthesis ↑ Production of IgG2g, IgG3 from activated plasma B cells ↑ MHC I and ↑ MHC II expression by APCs Promotes adhesion binding for leukocyte migration Retards collagen synthesis and cross-linking; stimulates collagenase activity | Also called macrophage activating factor Critical for both innate and adaptive immunity Antiviral INF-γ binds to glycosaminoglycan heparin sulfate at the cell surface, binding in general inhibits biological activity |
ADIPOCYTOKINES | |||
C-reactive protein | Hepatocytes, adipocytes Synthesized by the liver in response to factors released by macrophage and adipocytes (eg, IL-6) | CRP is a ligand binding protein (calcium dependent), which facilitates the interaction between complement and both foreign and damaged host cells Enhances phagocytosis by macrophage Modulates endothelial cell functions by inducing the expression of adhesion/“sticky” molecules (ICAM-1, VCAM-1) Attenuates nitric oxide production by down-regulating NOS expression CRP’s level of expression is regulated by IL-6 | First pattern recognition receptor (PRR) to be identified. Acute phase protein. Physiological role is to bind phosphocholine expressed on the surface of dead or dying cells and some types of bacteria in order to activate the complement system via C1Q complex; therefore, phagocytosis is enhanced. Opsonic-mediated phagocytosis helps amplify the early innate immune response |
PROSTAGLANDIIN | Leukocytes and macrophage | Either constriction or dilation of vascular smooth muscle Acts on platelets, endothelium, and mast cells Causes aggregation or disaggregation of platelets Regulates inflammatory mediation Controls cell growth Acts on thermoregulatory center of hypothalamus to produce fever Enzymatic pathway to convert the intermediate arachidonic acid to prostaglandin is found in active WBCs and macrophage | Prostaglandins are potent but have a short half-life before being activated or excreted. Therefore, send only autocrine (acting on the same cell from which it is synthesized) or paracrine (local adjacent cells) |
Growth factors are soluble polypeptides, produced in both normal and wounded tissues, which stimulate cell migration, proliferation, and alterations in cellular function. They are extremely potent and can exert significant effects in nanomolar concentrations. Growth factors bind to specific cell receptors and have one of two different effects: (1) the stimulation of DNA transcription or (2) the regulation of cell entry in the cell cycle (mitosis). Growth factors that are important in wound healing are listed in TABLE 2-4.
Growth Factors | Source | Functions |
Platelet-derived growth factor (PDGF) | Platelets, macrophages, endothelial cells, keratinocytes | Chemotactic for PMNs, macrophages, fibroblasts, activates PMNs, macrophages, and fibroblasts; mitogenic for fibroblasts, endothelial cells; stimulates production of MMPs, fibronectin, and HA; stimulates angiogenesis and wound contraction; remodeling |
Transforming growth factor-β (including isoforms β1, β2, and β3) (TGF-β) | Platelets, T-lymphocytes, macrophages, endothelial cells, keratinocytes, fibroblasts | Chemotactic for PMNs, macrophages, lymphocytes, and fibroblasts; stimulates TIMP synthesis, keratinocyte migration, angiogenesis, and fibroplasia; inhibits production of MMPs and keratinocyte proliferation; induces TGF-β production |
Epidermal growth factor (EGF) | Platelets, macrophages | Mitogenic for keratinocytes and fibroblasts; stimulates keratinocyte migration |
Transforming growth factor-α (TGF-α) | Macrophages, T-lymphocytes, keratinocytes | Similar to EGF |
Fibroblast growth factor-1 and -2 family (FGF) | Macrophages, mast cells, T-lymphocytes, endothelial cells, fibroblasts | Chemotactic for fibroblasts; mitogenic for fibroblasts and keratinocytes; stimulates keratinocyte migration, angiogenesis, wound contraction, and matrix deposition |
Keratinocyte growth factor (also called FGF-7) (KGF) | Fibroblasts | Stimulates keratinocyte migration, proliferation, and differentiation |
Insulin-like growth factor (IGF-I) | Macrophages, fibroblasts | Stimulates synthesis of sulfated proteoglycans, collagen, keratinocyte migration, and fibroblast proliferation; endocrine effects similar to those of growth hormone |
Vascular endothelial cell growth factor (VEGF) | Keratinocytes | Increases vasopermeability; mitogenic for endothelial cells |
Cell-to-wound matrix communication occurs extensively during debridement and angiogenesis. Matricellular proteins (defined as dynamically expressed non-structural proteins in the ECM that are rapidly turned over and have regulatory roles)57 destabilize the cell–matrix bonds and interactions, in essence creating a more fluid environment for cell migration. Proteinases, both plasminogen activators and matrix metalloproteinases (MMPs), act to dissolve the wound matrix both immediately after injury and during the proliferative and remodeling phases. This is necessary during angiogenesis for the directed migration of endothelial cells.
The intricacies of cellular communication involve the components of the extracellular matrix (ECM) including fibrous structural proteins, water-hydrated gels, and adhesive glycoproteins (FIGURE 2-17). The fibrous structural proteins include the collagens and elastins, which confer tensile strength and recoil to the tissue. Water-hydrated gels that permit resilience and lubrication are categorized as proteoglycans and hyaluronans. Adhesive glycoproteins connect the matrix elements to one another and to cells.
FIGURE 2-17
Extracellular matrix
The extracellular matrix (ECM) is complex and intimately involved in healing by regulating growth factor activation, cell signaling, and cell-to-matrix signaling. This figure illustrates the intricate positioning and connections of the glycoproteins, integrins, and proteoglycans that compose the ECM. It serves as the scaffolding upon which the body builds replacement tissue.
Collagen, one of the two fibrous structural proteins, is composed of three separate polypeptide chains braided into a rope like a triple helix (FIGURE 2-18). There are approximately 50 types of identified collagen. Some collagen types (eg, I, II, III, V) form fibrils by virtue of lateral cross-linking of the triple helix and are a major portion of connective tissue in healing wounds and particularly in scars. The cross-linking is a result of a covalent bond catalyzed by the enzyme lysyl oxidase, a process that is dependent on vitamin C. Types of collagen important to wound healing include Type I, skin and bone; Type IV, basement membrane; and Type VIII, dermal–epidermal junction.
FIGURE 2-18
Collagen triple helix
Collagen triple helix is schematically detailed illustrating the right-handed supercoil. In mature collagen, three polypeptide chains are braided into a triple helix rope. Glycine, proline (x), and hydroxyproline (y) are arranged in a right-handed supercoil that is approximately 1.5 nm in diameter. The three α-chains may be constructed of the same type of collagen (collagen II) or different (collagen I). Some collagen types (eg, collagen I, II, III, V) form fibrils by virtue of lateral cross-linking of the triple helix. Cross-linking is a result of covalent bonds catalyzed by the enzyme lysyl-oxidase, a process that is dependent upon vitamin C. About 50 types of collagen have been identified. Fibrillar collagens are a major component of connective tissue in healing wounds, particularly scars.
Elastin (present mainly in the skin, large vessels, ligaments, and uterus) consists of a central core of elastin surrounded by a mesh-like network of fibrillin glycoprotein. Fibroblasts secrete fibrillin into the ECM where it becomes assimilated into insoluble microfibrils and provides a platform for elastin deposition (FIGURE 2-19).
Proteoglycans form extremely hydrated compressible gels that provide both resilience and lubrication (eg, in the skin, cartilage, and joints). Proteoglycans consist of glycosaminoglycans (GAGs) and hyaluronan. GAGs are long polysaccharide chains like heparin sulfate and dermatan sulfate. Hyaluronan binds water and forms a very viscous, gelatin-like matrix. Proteoglycans also function to provide compressibility and serve as a reservoir for growth factors that are secreted into the ECM. Proteoglycans are also an important component of cell membranes and as such have roles in proliferation, migration, and adhesion (FIGURE 2-20).
FIGURE 2-20
Proteoglycan structure
Proteoglycans are aggregated in a pinnate, feather-like arrangement. The heterogenic proteoglycans are represented and further subdivided by common types. Proteoglycans form highly hydrated and compressible gels conferring resilience and lubrication (cartilage and joints). They consist of glycosaminoglycans (GAGs), which are long polysaccharide chains designated by their components (eg, heparin or dermatan sulfates). The hyaluronan components bind water and form a viscous gelatin-like matrix. Functionally, the proteoglycans provide tissue compressibility, serve as a reservoir for growth factors (ECM), and are an integral portion in the cell membranes. As part cellular membranes, these proteins have important roles in proliferation, migration, and adhesion.
The adherent components of the ECM are the adhesive glycoproteins and adhesion receptors. The adhesive glycoproteins include fibronectin and laminin. The adhesion receptors include immunoglobulin, selectin, cadherins, and integrins. Together laminin and fibronectin, by adjoining to collagen and connecting to the cellular plasma membrane of cells primary to tissue healing, reestablish both strength and function to the new replacement tissue. Laminin and fibronectin also form the critical active junction providing both orientation and a dynamic functioning framework. FIGURE 2-21 depicts the adhesion receptors, which are paramount to ECM function and structure.
Wound healing initially appears so very simple.58–60 The human body is designed to heal, repair, and in some cases regenerate lost tissue through a well-orchestrated sequence of events. When it proceeds as planned—though infinitely complex—healing is elegant, rapid, and efficient. The following four phases of wound healing are delineated by the pertinent vascular, cell-signaling, cellular activity, and clinical response as previously defined (FIGURE 2-10 to 2-14B).
With an acute injury, the small blood vessels respond initially with vasoconstriction to stem further blood loss and tissue injury (FIGURE 2-22). Activated platelets adhere to the endothelium and eject adenosine diphosphate (ADP) which promotes the clumping of thrombocytes and further ensures clot formation. The clot, composed of various cell types (red blood cells, white blood cells, and platelets), is stabilized by fibers of fibrin.17 (See FIGURES 2-23 and 2-24.)
Alpha granules containing platelet-derived growth factor (PDGF), platelet factor IV, and transforming growth factor beta (TGF-β) are released from the platelets. Dense bodies contained within the thrombocytes release vasoactive amines, including histamine and serotonin. PDGF is chemotactic for fibroblasts, and in coordination with TGF-β modulates mitosis of fibroblasts,61 thereby increasing the number of fibroblasts in close proximity to the wound. Fibrinogen is cleaved into fibrin which undergirds the structural support for the completion of the coagulation process and provides an active lattice for the important cellular components during the inflammatory phase. The fibrin will further serve as a scaffold for other infiltrating cells and proteins. (See TABLE 2-5.3,10,62) Clinically, a full-thickness wound bed with a stable clot functions to mitigate blood loss. Clear proteinaceous exudate may or may not be present.
Platelet α-granules secrete: | |
Platelet-derived growth factor | |
Transforming growth factor | |
Insulin-like growth factor | |
Fibronectin | |
Fibrinogen | |
Thrombospondin | |
von Willebrand factor | |
The dense bodies contain vasoactive amines like serotonin, which lead to increased vascular permeability and vasodilatation. |
Inflammation presents clinically as rubor (redness), tumor (swelling), calor (heat), and dolor (pain). The orchestrated arrival and departure of important cell mediators are depicted in FIGURE 2-25. Important changes that permit the initiation of inflammation and result in the clinical findings associated with inflammation are summarized in TABLE 2-6.
|